EUVIMEDEUVIMED entdecken
Crossref

The New Vaccine Surveillance Network: 25 Years of Active, Population-Based Surveillance for Pediatric Infectious Diseases in the United States

Daniel C Payne iD, Geoffrey A Weinberg iD, Natasha B Halasa, Janet A Englund iD, Julie A Boom, Rangaraj Selvarangan iD, Marian G Michaels iD, John V Williams iD, Leila C Sahni iD, Eileen J Klein, Christopher J Harrison iD, Jennifer E Schuster iD und 10 weitere

Clinical Infectious Diseases · 13.07.2026

DOI: 10.1093/cid/ciag434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 13.07.2026. Verfasst von Daniel C Payne und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Die Arbeit nennt 118 Literaturangaben. Gefördert von: NCIRD CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 1999, the Centers for Disease Control and Prevention established the New Vaccine Surveillance Network (NVSN) as a multisite pediatric infectious diseases active surveillance system.

Methods

NVSN prospectively collects population-based clinical, epidemiologic, and laboratory information on children who seek medical care at hospitals, emergency departments, urgent care centers, and outpatient clinics with symptoms of acute respiratory infections (ARI) and acute gastroenteritis (AGE) in the United States.

Results

These efforts have clearly established the significant burden of both ARI and AGE in US children, demonstrated the effectiveness of licensed pediatric vaccines, and helped guide their use. The surveillance platform also measures the real-world impact of preventive measures intended to avoid or ameliorate adverse child health outcomes within the US healthcare system. Furthermore, NVSN provides a platform for detecting and evaluating emerging infections (eg, enterovirus D-68 and severe acute respiratory syndrome coronavirus 2) and unexpected sequelae in children.

Conclusions

For 25 years, NVSN has provided an evidence-based foundation for pediatric infectious disease policy decision-making through objective, empirical data. Sustained investment in disease surveillance guides the scientific principles and public health practices that prevent suffering and premature death, prepares us for new and existent pathogen threats, and enables wise economic decisions that improve the health of Americans.

Schlagwörter

Stichwörter der Autor:innen

EV-D68New Vaccine Surveillance NetworkPREVAIL CohortRSVSARS-CoV-2disease burdenemerging infectious diseaseshealth policyinfluenzanoroviruspediatric infectionspopulation-based surveillancerotavirusvaccine effectiveness

Autor:innen und Institutionen

  • Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Seattle Children's Research Institute, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Texas Children's Hospital, Houston, Texas, USA.

ORCID-Profile: Daniel C Payne, Geoffrey A Weinberg, Janet A Englund, Rangaraj Selvarangan, Marian G Michaels, John V Williams, Leila C Sahni, Christopher J Harrison, Jennifer E Schuster, Elizabeth P Schlaudecker, Sara A Mirza, Heidi L Moline, Mary Allen Staat

Förderung

  • NCIRD CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Payne, D. C., Weinberg, G. A., Halasa, N. B., Englund, J. A., Boom, J. A., Selvarangan, R., Michaels, M. G., Williams, J. V., Sahni, L. C., Klein, E. J., Harrison, C. J., Schuster, J. E., Schlaudecker, E. P., Griffin, M. G., Edwards, K. M., Mirza, S. A., Moline, H. L., Dawood, F. S., Parashar, U. D., …, & NVSN Collaborators (2026). The New Vaccine Surveillance Network: 25 Years of Active, Population-Based Surveillance for Pediatric Infectious Diseases in the United States. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag434

Vancouver

Payne DC, Weinberg GA, Halasa NB, Englund JA, Boom JA, Selvarangan R, et al. The New Vaccine Surveillance Network: 25 Years of Active, Population-Based Surveillance for Pediatric Infectious Diseases in the United States. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag434

BibTeX
@article{Payne2026,
  author = {Payne, Daniel C and Weinberg, Geoffrey A and Halasa, Natasha B and Englund, Janet A and Boom, Julie A and Selvarangan, Rangaraj and Michaels, Marian G and Williams, John V and Sahni, Leila C and Klein, Eileen J and Harrison, Christopher J and Schuster, Jennifer E and Schlaudecker, Elizabeth P and Griffin, Marie G and Edwards, Kathryn M and Mirza, Sara A and Moline, Heidi L and Dawood, Fatimah S and Parashar, Umesh D and Staat, Mary Allen and Szilagyi, Peter G and NVSN Collaborators, NVSN Collaborators},
  title = {The New Vaccine Surveillance Network: 25 Years of Active, Population-Based Surveillance for Pediatric Infectious Diseases in the United States},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag434}
}
Kostenlos starten →